Bank of Jackson Hole Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,298
Closed -$1.59M 2
2026
Q1
$1.59M Buy
7,298
+85
+1% +$18.9K 0.77% 30
2025
Q4
$1.65M Buy
7,213
+44
+0.6% +$10K 0.78% 27
2025
Q3
$1.66M Buy
7,169
+400
+6% +$81.5K 0.83% 28
2025
Q2
$1.26M Buy
6,769
+573
+9% +$106K 0.71% 30
2025
Q1
$1.3M Sell
6,196
-72
-1% -$14K 0.84% 28
2024
Q4
$1.11M Buy
+6,268
New +$1.15M 0.74% 30

Other funds holding ABBV

Bank of Jackson Hole Trust's ABBV Position: Q2 2026 in Review

Bank of Jackson Hole Trust sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 7,298 shares — an estimated $1.59M sold.

Bank of Jackson Hole Trust first reported a position in ABBV in Q4 2024 and held it in 6 quarters. The position peaked at $1.66M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bank of Jackson Hole Trust reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 7,298 AbbVie shares in Q2 2026, an estimated $1.59M.
  • Bank of Jackson Hole Trust first reported a position in AbbVie in Q4 2024 and held it in 6 quarters.
  • Bank of Jackson Hole Trust's AbbVie position peaked at $1.66M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2026.